Day: October 13, 2021

PDS Biotechnology Announces Conference Call and Webcast to Present Third-Quarter 2021 Financial Results

PDS Biotechnology Announces Conference Call and Webcast to Present Third-Quarter 2021 Financial Results

FLORHAM PARK, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, will release financial results for the third quarter of 2021 on Wednesday, November 10, 2021, before the market opens. Following the release, management will host a conference call to review the company’s financial results and provide a business update. The conference call is scheduled to begin at 8:00 am ET on Wednesday, November 10, 2021. Participants should dial 877-407-3088 (United States) or 201-389-0927 (International) and mention PDS Biotechnology. A live webcast of the conference call will also be available on the investor relations page of the Company’s website at www.pdsbiotech.com. After...

Continue reading

Globus Medical Files Suit Against Life Spine for IP Infringement

Globus Medical Files Suit Against Life Spine for IP Infringement

Action Seeks Relief to Prevent Further Infringement of Globus Medical Patents AUDUBON, Pa., Oct. 13, 2021 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today filed a lawsuit against Life Spine, Inc. alleging infringement of seven different patents related to Globus Medical’s expandable interbody spacer technology. This action involves a number of products manufactured by Life Spine, and marketed by them and other companies. The suit was filed in the United States District Court for the District of Delaware, seeking injunctive relief and damages for infringement. “Globus Medical is the leader in expandable interbody technology, creating meaningful advancements in treatment options for surgeons who treat patients affected by degenerative disc disease of the lumbosacral spine,”...

Continue reading

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021

SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2021 financial and operating results after the market closes on Wednesday, November 10, 2021, and will host a conference call on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call, dial (833) 693-0536 or (661) 407-1576 and enter the conference ID number 9136747. For 72 hours following the call, an audio replay can be accessed by dialing (855) 859-2056 or (404) 537-3406 and using the conference ID number above. The call will also be available via live or archived webcast on the “Investors” section of the Maravai web site at investors.maravai.com. About Maravai Maravai...

Continue reading

AXT, Inc. Schedules Third Quarter 2021 Earnings Release for October 27, 2021

AXT, Inc. Schedules Third Quarter 2021 Earnings Release for October 27, 2021

FREMONT, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) — AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor substrates, will announce its financial results for the third quarter 2021 in a press release immediately following the close of market on October 27, 2021. The company will also host a conference call to discuss these results on October 27, 2021 at 1:30 p.m. PT. The conference call can be accessed at (844) 892-6598 (passcode 8289338). The call will also be simulcast at www.axt.com. Replays will be available at (855) 859-2056 (passcode 8289338) until November 3, 2021. Financial and statistical information to be discussed in the call will be available on the company’s website immediately prior to commencement of the call. Additional investor information can be accessed at http://www.axt.com or by calling...

Continue reading

InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids

InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids

VANCOUVER, British Columbia and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that they have completed the previously announced acquisition of BayMedica Inc. (“BayMedica”), a private company based in the US specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. Eric A. Adams, President and Chief Executive Officer of InMed, stated, “We are delighted to close this acquisition and welcome everyone at BayMedica to the InMed team. In the next several weeks, we will focus on corporate integration, exploring our combined manufacturing know-how and looking to accelerate revenue growth. BayMedica brings significant...

Continue reading

WPT Industrial Real Estate Investment Trust Receives Court Approval for Arrangement with Blackstone Real Estate Income Trust

WPT Industrial Real Estate Investment Trust Receives Court Approval for Arrangement with Blackstone Real Estate Income Trust

TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) — WPT Industrial Real Estate Investment Trust (the “REIT”) (TSX: WIR.U; WIR.UN – OTCQX: WPTIF) is pleased to announce that the Supreme Court of British Columbia has issued a final order approving its previously announced plan of arrangement pursuant to which an affiliate of Blackstone Real Estate Income Trust, Inc. will acquire all of the outstanding trust units of the REIT (each, a “Unit”) through a series of transactions that will result in unitholders of the REIT (“Unitholders”) receiving US$22.00 per Unit in cash, subject to applicable withholdings (the “Transaction”). Completion of the Transaction remains subject to the satisfaction or waiver of certain customary closing conditions. The effective date of the Transaction will be October 20, 2021, subject to the terms and conditions...

Continue reading

Hingham Savings Reports Third Quarter 2021 Results

Hingham Savings Reports Third Quarter 2021 Results

HINGHAM, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced third quarter results for 2021. Earnings Net income for the quarter ended September 30, 2021 was $14,012,000 or $6.54 per share basic and $6.36 per share diluted, as compared to $15,206,000 or $7.12 per share basic and $6.96 per share diluted for the same period last year. The Bank’s annualized return on average equity for the third quarter of 2021 was 16.57%, and the annualized return on average assets was 1.85%, as compared to 22.23% and 2.26% for the same period in 2020. Net income per share (diluted) for the third quarter of 2021 decreased by 9% over the same period in 2020. Core net income for the quarter ended September 30, 2021, which represents net income excluding the after-tax gains and losses...

Continue reading

Cricut to Announce Third Quarter 2021 Financial Results on November 10, 2021

Cricut to Announce Third Quarter 2021 Financial Results on November 10, 2021

SOUTH JORDAN, Utah, Oct. 13, 2021 (GLOBE NEWSWIRE) — Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced it will report its financial results for the third quarter ended September 30, 2021 after the U.S. markets close on Wednesday, November 10, 2021. Cricut management will host a conference call and webcast to discuss the results that afternoon at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time). Information about Cricut’s financial results, including a link to the live and archived webcast of the conference call, will be made available on Cricut’s investor relations website at https://investor.cricut.com. The live call may also be accessed via telephone at (833) 398-1017 toll-free domestically and at (914) 987-7715...

Continue reading

Clearway Energy, Inc. to Report Third Quarter 2021 Financial Results on November 4, 2021

Clearway Energy, Inc. to Report Third Quarter 2021 Financial Results on November 4, 2021

PRINCETON, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) plans to report Third Quarter 2021 financial results on Thursday, November 4, 2021. Management will present the results during a conference call and webcast at 8:00 a.m. Eastern. A live webcast of the conference call, including presentation materials, can be accessed through the Company’s website at http://www.clearwayenergy.com and clicking on “Presentations & Webcasts” under the Investor Relations section. The webcast will be archived on the site for those unable to listen in real time. About Clearway Energy Clearway Energy, Inc. is one of the largest renewable energy owners in the US with over 4,700 net MW of installed wind and solar generation projects. Clearway Energy’s over 8,000 net MW of assets also includes approximately 2,500...

Continue reading

Oil-Dri Announces Fourth Quarter and Fiscal 2021 Results

Oil-Dri Announces Fourth Quarter and Fiscal 2021 Results

CHICAGO, Oct. 13, 2021 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its fourth quarter and fiscal year 2021.   Fourth Quarter Year to Date (in thousands, except per share amounts) Ended July 31 Ended July 31   2021   2020   Change 2021 2020 Change Consolidated Results             Net Sales $78,129 $64,844   20  % $304,981 $283,227 8  % Net Income Attributable to Oil-Dri $603 $5,886   (90 )% $11,113 $18,900 (41 )% Earnings per Common Diluted Share $0.08 $0.83   (90 )% $1.57 $2.65 (41 )% Business to Business             Net Sales $30,022 $26,628   13  % $110,120 $104,260 6  % Segment Operating Income* $3,791 $6,255   (39 )% $25,086 $26,882 (7 )% Retail and Wholesale             Net Sales $48,107 $38,216   26  % $194,861 $178,967 9  % Segment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.